Adequacy of information delivered to patients during consultation for thyrotoxicosis [1]

Clinical Endocrinology

Volumn 61, Issue 6, 2004, Pages 778-779

  Kaushal, K ^a   Bhattacharyya, A ^a   Gibson, C M ^a   Varghese, B ^a   Davis, J R E ^a  

^a MANCHESTER ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHYROID AGENT;

ADULT; AGE; AGED; AGRANULOCYTOSIS; CONSULTATION; CONTROLLED STUDY; FEMALE; HEART PALPITATION; HEAT TOLERANCE; HUMAN; LETTER; MAJOR CLINICAL STUDY; MALE; MEDICAL INFORMATION; PATIENT EDUCATION; PRIORITY JOURNAL; QUESTIONNAIRE; SORE THROAT; SYMPTOMATOLOGY; THYROTOXICOSIS; WEIGHT REDUCTION;

ADULT; AGED; AGED, 80 AND OVER; ANTITHYROID AGENTS; HUMANS; MIDDLE AGED; PATIENT EDUCATION; THYROTOXICOSIS;

EID: 10844287882     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2004.02141.x     Document Type: Letter

References (3)

1. Callahan, E.J., Bertakis, K.D., Azari, R., Robbins, J.A., Helms, L.J. & Chang, D.W. (2000) The influence of patient age on primary care resident physician-patient interaction. Journal of the American Geriatrics Society, 48, 30-35.
2. Cooper, D.S. (2003) Antithyroid drugs in the management of patients with Graves' disease: an evidence-based approach to therapeutic controversies. Journal of Clinical Endocrinology and Metabolism, 88, 3474-3481.
3. Lincoln, N.B., Sturrock, N.D., Sowter, H., Abbott-Harland, S., Nichols, E. & Jeffcoate, W.J. (2000) Patient education in thyrotoxicosis. Patient Education and Counseling, 40, 143-149.